Search
Now showing items 1-6 of 6
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Haemodynamic effects of no and vitamin C supplementation in SHR with acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2006)
Incidence of anti-alfa fodrin antibodies in primary sjogren syndrome and its correlation with anti ro/SS-A and anti La/SS-B antibodies
(BMJ Publishing Group, London, 2006)
Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: Seroprevalence and risk factors
(Elsevier Science Bv, Amsterdam, 2006)
Toxoplasmosis is a globally distributed zoonosis with a clinical impact in the unborn fetus and in the immunosuppressed individual. In Serbia, studies of risk factors for Toxoplasma gondii infection in humans have shown ...
Plasma fatty acid composition in overweight patients with hypertriglyceridemia
(Elsevier Ireland Ltd, Clare, 2006)
Erythrocyte fatty acid composition in obese patients with hyperlipidemia
(Elsevier Ireland Ltd, Clare, 2006)